Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-03-01 @ 9:58 AM
Study NCT ID:
NCT03055559
Status:
COMPLETED
Last Update Posted:
2018-03-14
First Post:
2017-02-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial Protocol GlobiFer - Oral Iron Repletion
Sponsor:
Gedeon Richter Slovakia, s.r.o.
Organization:
Study Overview
Official Title:
Oral Iron Repletion With Globifer Forte® After 12 Weeks of Treatment
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TPG
Brief Summary:
The haemoglobin level of the patients with iron deficiency should be increased clinical relevant after 12 weeks treatment with GlobiFer Forte.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: